Reefer Gladness? DEA OKs Catalent to supply marijuana from Missouri plant
Catalent has registered a facility in Missouri with the US DEA to import cannabis extracts in dosage form for clinical trial studies.
Archives for December 9, 2015
Facing an anti-venom shortage, WHO tries to mobilise new suppliers
Sanofi's recent decision to stop making anti-venom could lead to shortages from next year and place the lives of thousands of people in jeopardy, says the World Health Organisation (WHO).
Dependence on Medidata sets INC apart from IT-hungry CRO crowd, analyst
Reliance on third-party software vendors differentiates INC Research from its technology-investing peers but will not be a disadvantage, according to a Jefferies analyst.
Severe shortage? 1,500 inspectors too few for India's 10,000 plants says ASSOCHAM
New Delhi industry group ASSOCHAM says international criticism of Indian drug and API plants is due to a ‘severe shortage’ of regulatory inspectors.
FDA ‘best practices’ guide seeks to speed drug development
Early and efficient communication is the key to cutting approval times says the US FDA, which published a draft best practices guide for drug firms this week.
Expert predicts more CROs will buy trial sites after Icon deal
Growth-hungry CROs will buy trial sites according to David Blume from Edgemont Capital Partners, who told us Icon's acquisition of PMG Research is part of an emerging trend.
Ibuprofen gels not a patch on new delivery tech say UK developers
UK researchers have developed an ibuprofen patch they claim offers better dosage control than gel formulations of the pain drug.